Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yandex.Drive will start working in Saratov

12/10/24 YDEX

Yandex will launch unmanned trucks on the M-11 and M-12 highways in 2025

12/10/24 YDEX

Polyus plans to double its gold output by 2030

12/10/24 PLZL

VTB buys Post Bank for ₽36 billion

12/10/24 VTBR

Ozon to launch Russia's first e-commerce customs warehouse

12/10/24 OZON

Commissioning of the first line of the Sukhogogo Log Mill is scheduled for 2028

12/10/24 PLZL

Sminex agrees to sell part of Ingrad's projects

12/10/24 INGR

Cherkizovo acquired a poultry farming complex in the Tyumen region

12/10/24 GCHE

Shareholders of Renaissance Insurance approved dividends

12/10/24 RENI

Sberbank reports for 11 months of 2024 by RAS

12/10/24 SBER